Cigna’s CEO waved off concerns that the HHS’ proposal to curtail PBM drug rebates could disrupt its business. Cigna reported higher revenue and lower profit in the fourth quarter of 2018 after bringing Express Scripts into the fold.
Cigna’s CEO waved off concerns that the HHS’ proposal to curtail PBM drug rebates could disrupt its business. Cigna reported higher revenue and lower profit in the fourth quarter of 2018 after bringing Express Scripts into the fold.